Bionano Genomics, Inc. (Nasdaq: BNGO) today announced Bionano Symposium 2026, the premier global event for the optical genome mapping (OGM) community. This virtual symposium provides a unique platform ...
SAN DIEGO, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced a peer-reviewed study published in Molecular Therapy - Methods & Clinical Development, describing the ...
SAN DIEGO - Bionano Genomics, Inc. (NASDAQ:BNGO) announced Wednesday that a peer-reviewed study has demonstrated the effectiveness of optical genome mapping (OGM) in detecting genomic alterations ...
9don MSN
The 'zombie cell' effect: New study explains chemotherapy resistance in lung and ovarian cancers
Researchers have identified a biological mechanism that helps explain why some lung and ovarian cancers become resistant to chemotherapy, offering insight into why cancers recur. The study, published ...
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ...
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ...
[email protected] Sen. Shelley Moore Capito (R-W.Va.), chairman of the Senate Labor, Health and Human Services, Education, and Related Agencies Appropriations Subcommittee, has announced ...
Cannabis Bioscience International Holdings, Inc. engages in the provision of educational systems that focuses on medical cannabis in the United States and Latin America, and internationally. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results